We discuss the communities, meeting spaces, policies, promises, and challenges for novel technologies working with cells and tissues outside the body, including (but not limited to) 3D bioprinting, upscale, synthetic biology, organogenesis, biobanking, and forms of gene editing operating in vitro.
Scientists and technologists are ever increasing the number of ways cells and tissues can be used and manipulated. This panel looks at these communities, meeting spaces, policies, promises and challenges for novel techniques working with cells and tissues outside of the body. In the context of new technology horizons, new health bioeconomies, and new ethical discourses, it remains vital that STS inspects innovation (and stagnation) as cells and tissues are produced, stored, manipulated, and collectively assembled in research, commercial, clinical, and industrial contexts. The panel welcomes papers on techniques including (but not limited to) 3D bioprinting, upscaling tissue production, synthetic biology, organogenesis, biobanking, and forms of gene editing operating in vitro (including cases when subsequent in vivo application is envisaged). While it is likely a number of papers in the session will consider biomedical contexts, it is not limited to that, and we look hope for papers exploring cellular or tissue level work in other domains.